Mary Patrice Eastwood

Mary Patrice Eastwood

Auto-generated profile, based on publicly available information

Mary Patrice Eastwood

Department of Development and Regeneration, Katholieke Universiteit Leuven, Leuven, Belgium

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 May 2015 in Pediatric Pulmonology
Verified
Journal Article
Closed access
PDF file
MEMary Patrice Eastwood
Mary Patrice Eastwood
FRFrancesca Maria Russo
Francesca Maria Russo
JTJaan Toelen
Jaan Toelen
JDJan Deprest
Jan Deprest

22 June 2018 in Prenatal Diagnosis
Verified
Journal Article
Closed access
PDF file
MEMary Patrice Eastwood
Mary Patrice Eastwood
JDJan Deprest
Jan Deprest
FRFrancesca Maria Russo
Francesca Maria Russo
HWHongmei Wang
Hongmei Wang
DMDrew Mulhall
Drew Mulhall
RKRichard Keijzer
Richard Keijzer

12 June 2020 in Annals of Surgery
Verified
Journal Article
Closed access
FRFrancesca Maria Russo
Francesca Maria Russo
MCMarina Gabriela Monteiro Carvalho Mori Da Cunha
Marina Gabriela Monteiro Carvalho Mori Da Cunha
JJJulio Jiménez
Julio Jiménez
FLFlore Lesage
Flore Lesage
MEMary Patrice Eastwood
Mary Patrice Eastwood
JDJan Deprest
Jan Deprest
Objective: To evaluate the effect of combining antenatal sildenafil with fetal tracheal occlusion (TO) in fetal rabbits with surgically induced congenital diaphragmatic hernia (CDH). Background: Although antenatal sildenafil administration rescues vascular abnormalities in lungs of fetal rabbits with CDH, it only partially improves airway morphometry. We hypothesized that we could additionally stimulate lung growth by combining this medical treatment with fetal TO. Methods: CDH was created on gestational day (GD)23 (n=54). Does were randomized to receive either sildenafil 10 mg/kg/d or placebo by subcutaneous injection from GD24 to GD30. On GD28, fetuses were randomly assigned to TO or sham neck dissection. At term (GD30) fetuses were delivered, ventilated, and finally harvested for histological and molecular analyses. Unoperated littermates served as controls. Results: The lung-to-body-weight ratio was significantly reduced in sham-CDH fetuses either (1.2 ± 0.3% vs 2.3 ± 0.3% in controls, P=0.0003). Sildenafil had no effect on this parameter, while CDH fetuses undergoing TO had a lung-to-body-weight ratio comparable to that of controls (2.5 ± 0.8%, P<0.0001). Sildenafil alone induced an improvement in the mean terminal bronchiolar density (2.5 ± 0.8 br/mm2 vs 3.5 ± 0.9 br/mm2, P=0.043) and lung mechanics (static elastance 61 ± 36 cmH2O /mL vs 113 ± 40 cmH2O/mL, P=0.008), but both effects were more pronounced in fetuses undergoing additional TO (2.1 ± 0.8 br/mm2, P=0.001 and 31 ± 9 cmH2O/mL, P<0.0001 respectively). Both CDH-sham and CDH-TO fetuses treated with placebo had an increased medial wall thickness of peripheral pulmonary vessels (41.9 ± 2.9% and 41.8 ± 3.2%, vs 24.0 ± 2.9% in controls, P<0.0001). CDH fetuses treated with sildenafil, either with or without TO, had a medial thickness in the normal range (29.4% ± 2.6%). Finally, TO reduced gene expression of vascular endothelial growth factor and surfactant protein A and B, but this effect was counteracted by sildenafil. Conclusion: In the rabbit model for CDH, the combination of maternal sildenafil and TO has a complementary effect on vascular and parenchymal lung development.

28 July 2018 in Journal of Tissue Engineering and Regenerative Medicine
Verified
Journal Article
Closed access
PDF file
MEMary Patrice Eastwood
Mary Patrice Eastwood
WDWilleke F. Daamen
Willeke F. Daamen
LJLuc Joyeux
Luc Joyeux
SPSavitree Pranpanus
Savitree Pranpanus
RRRita Rynkevic
Rita Rynkevic
JDJan Deprest
Jan Deprest

2 February 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Open access
ADAikaterini Dedeloudi
Aikaterini Dedeloudi
FFFatima Farzeen
Fatima Farzeen
VLVlad-Nicolae Lesutan
Vlad-Nicolae Lesutan
RIRobyn Irwin
Robyn Irwin
MWMatthew P Wylie
Matthew P Wylie
Dimitrios A. LamprouDimitrios A. Lamprou
Dimitrios A. Lamprou
Congenital diaphragmatic hernia (CDH) is a rare disease in which neonates are born with pulmonary hypoplasia and a diaphragmatic defect. Survival is improving due to advances in fetal intervention for pulmonary hypoplasia leading to increased use of scaffolds for repair. Scaffolds have a significant morbidity rate with recurrence, small bowel obstruction and infrequently postoperative infections. 3D printing (3DP) is a promising technology for the fabrication of personalized medical devices characterised by a more precise and targeted approach to tissue engineering and drug delivery. In this study, blank thermoplastic polyurethane (TPU) and gentamicin sulfate (GNS)-loaded filaments (1 % and 1.5 %wt.) were fabricated with hot melt extrusion (HME) and subsequently processed through 3DP for scaffold manufacturing. Geometrical attributes of the scaffolds, including a specific % infill, were predefined through computer aided design (CAD) and printing parameters were optimised. Physicochemical analysis involving material compatibility and thermal properties of all formulations were examined, determining their thermal and chemical stability during 3DP. Mechanical analysis showed that polymeric matrixes resemble to diaphragm tissue, exhibiting adequate and reproducible elastic performance, while cell studies confirmed TPU's supportive capacity for cellular attachment. Additionally, in vitro dissolution and bacterial studies were carried out for up to a week, denoting GNS's sustained release from the polymeric matrices and efficient bactericidal activity to Gram-positive and Gram-negative bacteria, respectively. Therefore, TPU is a potential biomaterial that can be efficiently used for developing diverse 3D printed diaphragm-like scaffolds possessing antimicrobial activity for CDH.

1 July 2014 in The Cleft Palate Craniofacial Journal
Verified
Journal Article
Closed access
MEMary P. Eastwood
Mary P. Eastwood
KHKoh H. Hoo
Koh H. Hoo
DADavid Adams
David Adams
CHChristopher Hill
Christopher Hill
Objective: To determine uptake and outcome of hearing screening in the cleft palate population in Northern Ireland (NI) and the rate of ventilation tube (VT) insertion over a 3-year period. Design: In NI, hearing screening is offered in the neonatal period, at 9 months in the community, and at 2.5 years in the joint cleft clinic. Patients: Eighty-five children with cleft palate born between 2006 and 2008 in NI were eligible for all three screenings. Methods: A retrospective case note review was performed of tympanograms, audiometry, and VT insertion rates at each of the three time points. Results: In the neonatal period, all patients eligible were screened; 66 (77.6%) patients passed the screening, with 19 patients (22.4%) failing, resulting in direct referral to ENT for consideration of VT. Results of the 9-month community screening were not made routinely available to the regional cleft service. At the 2.5-year clinic screening, all attending patients (n = 80) had documented screening. Fifty-two (65%) patients passed screening, with 28 patients (35%) failing screening. Forty-six patients (57.5%) had documented VT, and 9 (11.25%) were awaiting ENT review for consideration of VT. Conclusion: Ventilation tubes are not routinely inserted at the time of cleft repair in the NI population, and 57.5% of our cleft population has ventilation tubes inserted by 2.5 years. Cleft patients in NI have regular routine hearing assessments, and our current practice avoids universal ventilation tube insertion while identifying those who need further hearing management. Further research is needed to reach an international consensus on the insertion of VT in cleft patients.